IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.

Despite effective chemotherapy to treat schistosome infections, re-infection rates are extremely high. Resistance to reinfection can develop, however it typically takes several years following numerous rounds of treatment and re-infection, and often develops in only a small cohort of individuals. Us...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark S Wilson, Allen W Cheever, Sandra D White, Robert W Thompson, Thomas A Wynn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-08-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1002171&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849727709701210112
author Mark S Wilson
Allen W Cheever
Sandra D White
Robert W Thompson
Thomas A Wynn
author_facet Mark S Wilson
Allen W Cheever
Sandra D White
Robert W Thompson
Thomas A Wynn
author_sort Mark S Wilson
collection DOAJ
description Despite effective chemotherapy to treat schistosome infections, re-infection rates are extremely high. Resistance to reinfection can develop, however it typically takes several years following numerous rounds of treatment and re-infection, and often develops in only a small cohort of individuals. Using a well-established and highly permissive mouse model, we investigated whether immunoregulatory mechanisms influence the development of resistance. Following Praziquantel (PZQ) treatment of S. mansoni infected mice we observed a significant and mixed anti-worm response, characterized by Th1, Th2 and Th17 responses. Despite the elevated anti-worm response in PBMC's, liver, spleen and mesenteric lymph nodes, this did not confer any protection from a secondary challenge infection. Because a significant increase in IL-10-producing CD4(+)CD44(+)CD25(+)GITR(+) lymphocytes was observed, we hypothesised that IL-10 was obstructing the development of resistance. Blockade of IL-10 combined with PZQ treatment afforded a greater than 50% reduction in parasite establishment during reinfection, compared to PZQ treatment alone, indicating that IL-10 obstructs the development of acquired resistance. Markedly enhanced Th1, Th2 and Th17 responses, worm-specific IgG1, IgG2b and IgE and circulating eosinophils characterized the protection. This study demonstrates that blocking IL-10 signalling during PZQ treatment can facilitate the development of protective immunity and provide a highly effective strategy to protect against reinfection with S. mansoni.
format Article
id doaj-art-9053d5f2037340eaa4ba0f256bb8350e
institution DOAJ
issn 1553-7366
1553-7374
language English
publishDate 2011-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-9053d5f2037340eaa4ba0f256bb8350e2025-08-20T03:09:47ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742011-08-0178e100217110.1371/journal.ppat.1002171IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.Mark S WilsonAllen W CheeverSandra D WhiteRobert W ThompsonThomas A WynnDespite effective chemotherapy to treat schistosome infections, re-infection rates are extremely high. Resistance to reinfection can develop, however it typically takes several years following numerous rounds of treatment and re-infection, and often develops in only a small cohort of individuals. Using a well-established and highly permissive mouse model, we investigated whether immunoregulatory mechanisms influence the development of resistance. Following Praziquantel (PZQ) treatment of S. mansoni infected mice we observed a significant and mixed anti-worm response, characterized by Th1, Th2 and Th17 responses. Despite the elevated anti-worm response in PBMC's, liver, spleen and mesenteric lymph nodes, this did not confer any protection from a secondary challenge infection. Because a significant increase in IL-10-producing CD4(+)CD44(+)CD25(+)GITR(+) lymphocytes was observed, we hypothesised that IL-10 was obstructing the development of resistance. Blockade of IL-10 combined with PZQ treatment afforded a greater than 50% reduction in parasite establishment during reinfection, compared to PZQ treatment alone, indicating that IL-10 obstructs the development of acquired resistance. Markedly enhanced Th1, Th2 and Th17 responses, worm-specific IgG1, IgG2b and IgE and circulating eosinophils characterized the protection. This study demonstrates that blocking IL-10 signalling during PZQ treatment can facilitate the development of protective immunity and provide a highly effective strategy to protect against reinfection with S. mansoni.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1002171&type=printable
spellingShingle Mark S Wilson
Allen W Cheever
Sandra D White
Robert W Thompson
Thomas A Wynn
IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.
PLoS Pathogens
title IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.
title_full IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.
title_fullStr IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.
title_full_unstemmed IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.
title_short IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.
title_sort il 10 blocks the development of resistance to re infection with schistosoma mansoni
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1002171&type=printable
work_keys_str_mv AT markswilson il10blocksthedevelopmentofresistancetoreinfectionwithschistosomamansoni
AT allenwcheever il10blocksthedevelopmentofresistancetoreinfectionwithschistosomamansoni
AT sandradwhite il10blocksthedevelopmentofresistancetoreinfectionwithschistosomamansoni
AT robertwthompson il10blocksthedevelopmentofresistancetoreinfectionwithschistosomamansoni
AT thomasawynn il10blocksthedevelopmentofresistancetoreinfectionwithschistosomamansoni